# Qatar Cardiovascular Biorepository of AF Patients

> **NCT03660696** · — · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 300 (estimated)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03660696
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2020-03
- **Final completion:** 2020-12
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2019-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03660696

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03660696, "Qatar Cardiovascular Biorepository of AF Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03660696. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*